Nasal Implants Market To 2019: Top Industry Players, Revenue By 2027

Global Nasal Implants Market – Introduction

Nose is a vital organ, which plays a significant role in respiration and facial appearance. The prominent and central position of the nose, makes it susceptible to injuries, deformities, and fractures. Congenital deformities, septal perforations, malignant destruction, trauma, nasal valve collapse, inflammation of the sinuses, nasal airway obstruction, and nasal polyps leading to difficulty in breathing are major causes for nasal reconstruction, which propels the demand for nasal implants.

Read Report Overview:

https://www.transparencymarketresearch.com/nasal-implants-market.html

Nasal implants are devices inserted in the nasal cavity during a nasal reconstruction surgery, which is used to correct deformities of the nose. Nasal implants are made of different materials including metal, ceramic, and polymers such as silicone, PTFE, and polyamides. Patient nasal anatomy, esthetic qualities, pathological defect, level of injury or deformity, patient perception for adoption of implants are significant factors considered during nasal reconstruction procedures.

Global Nasal Implants Market – Competitive Landscape

  • In April 2018, Intersect ENT, Inc. announced the launch of SINUVA (mometasone furoate) Sinus Implant in the U.S. It is a mometasone furoate steroid eluting sinus implant used in the treatment of adults with recurrent nasal polyps.
  • In June 2016, Stryker received 510(k) approval by the U.S. Food and Drug Administration (FDA) for its LATERA absorbable nasal implant. This is anticipated to expand the company’s product portfolio and increase customer base.

Intersect ENT, Inc.

Founded in 2003, Intersect ENT, Inc. is a commercial drug delivery company that primarily engages in the development of innovative and clinically effective medical therapies for physicians and patients used for the treatment of chronic inflammatory nasal diseases, including sinusitis and nasal polyps. It has developed a localized sinus drug delivery technology to transform ENT care. Intersect ENT, Inc. offers diverse steroid releasing implants including PROPEL family of products, and SINUVA (mometasone furoate) sinus implant.

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=70041

Global Nasal Implants Market – Dynamics

Increase in prevalence of nose and sinus disorders, globally, drives market

Rise in prevalence of nose and sinus diseases such as chronic sinusitis, nasal polyps, and nasal airway obstruction across the globe is a major factor driving the global nasal implants market. For instance, According to Center for Disease Prevention and Control (CDC), in 2017, approximately 30.0 million adults were affected with chronic rhinosinusitis in the U.S. Deviated septum in chronic rhinosinusitis patients is a major factor propelling the demand for nasal implants. Moreover, nasal airway obstruction (NAO) affects 20 million people in the U.S. each year. All these factors are anticipated to boost the demand for nasal implants in the near future.

Comments

comments

You may also like...